HCM Marketplace

WEBCAST ON CD

Sponsored by Pharma Compliance Alert

presented on May 14, 2008

Practical solutions to drug-rebate reporting problems

Failing to report discounted prices on its drugs cost Merck Pharmaceuticals $650 million. The ramifications of insufficient drug rebate reporting are steep—to both your organization’s bottom line and your shareholders perception of and confidence in your company.

Learn what risk areas to avoid by attending ePharmaceuticals’ Webcast: Drug Rebates: Mitigate Risks Uncovered by Recent Enforcement Actions. During this 60-minute Webcast, healthcare attorney Garineh S. Dovletian, Esq. (Porzio, Bromberg & Newman) uses examples from the recent settlements to identify what risk areas were exposed and what makes these areas risky. She will also detail specific methods of risk mitigation that you can apply to your organization. Your takeaway from this program will be a better understanding of what specific measures you can implement to protect your company.

At the conclusion of this Webcast, participants will be able to:

• Identify potential risk areas in your drug rebate policies
• Analyze procedures which cause actions to be risky in the first place
• Develop practical, applicable solutions to minimize and mitigate risk altogether

AGENDA

• Identification of risk areas from recent settlements
• Overview of Medicaid Rebate Program and key terms
• Review recent enforcement actions under Medicaid Rebate Program
• Examine practices under scrutiny

• Analysis of potential problems arising from identified risk areas
• Understand the underlying legal theories
• Identify lessons learned from prosecutions

• Solutions to mitigating risk
• Avoid actions that can result in penalties
• Implement best practices

• Q&A

MEET THE SPEAKER

Garineh S. Dovletian, Esq., counsel to Porzio, Bromberg & Newman. Garineh is a member of the firm’s Pharmaceutical Marketing and Sales Compliance and Litigation Department. She counsels pharmaceutical and device manufacturers on federal and state fraud and abuse laws, pricing issues, and state disclosure and prohibition laws. She develops policies and procedures and training programs for clients, in connection with their comprehensive compliance programs.  She also evaluates drug advertising and promotion, grants and contributions, and marketing activities directed to healthcare professionals.

WHO SHOULD ATTEND THIS WEBCAST?

Pharmaceutical professionals, including the following titles and departments:

• Compliance officers
• Legal department
• In-house counsel
• Outside counsel
• Finance officers
• Compliance analysts
• Rebate operations
• Contract marketing

PROGRAM MATERIALS

You will receive presentation slides, and other materials that you can print and distribute to all of your peers at your location. Purchase a CD of the program and listen when you can. It's also a perfect training tool for new staff or as a refresher for veteran staff.

• Webcasts

• Other Life Sciences Products